Katharine A. Phillips, M.D., is internationally renowned for her clinical expertise and pioneering medical research on body dysmorphic disorder (BDD). She also has expertise in obsessive-compulsive disorder, olfactory reference syndrome, anxiety disorders, and other psychiatric disorders.
Dr. Phillips is Adjunct Professor of Psychiatry and Human Behavior at the Alpert Medical School of Brown University. She is also Professor of Psychiatry, DeWitt Wallace Senior Scholar, and Residency Research Director in the Department of Psychiatry at Weill Cornell Medical College, Cornell University, in New York City, as well as Attending Psychiatrist at New York-Presbyterian Hospital, also in New York City. Her clinical practice is located at the Weill Cornell Psychiatry Specialty Center in Manhattan (http://weillcornellpsychiatrycenter.org/). To learn more about her clinical services, visit https://weillcornell.org/katharine-phillips-md or KatharinePhillipsMD.com, or call 646-962-2820.
Dr. Phillips is a physician and scientist who has spent her career caring for patients and conducting groundbreaking scientific research on BDD and other psychiatric disorders. Her research studies on BDD have identified many aspects of this severe psychiatric disorder. Much of her work has focused on developing and testing treatments, both medication treatment and cognitive-behavioral therapy (CBT) for BDD. Her scientific studies on BDD were continuously funded by the National Institute of Mental Health for more than 20 years.
Dr. Phillips has received numerous honors and awards for her research, clinical work, and other academic contributions, including a Special Presidential Commendation from the American Psychiatric Association for her research studies on BDD.
She has more than 325 publications (original scientific articles, review articles, letters, and book chapters). She has also written or edited 11 books on BDD and other topics. She has given more than 575 international, national, and local presentations for professionals, including more than 120 Grand Rounds.
Dr. Phillips is an elected Fellow of the American College of Neuropsychopharmacology and a Distinguished Fellow of the American Psychiatric Association. She is a member of numerous editorial boards, the American College of Psychiatrists, and the Scientific Advisory Boards of the Anxiety and Depression Association of America and the International OCD Foundation. She serves on the Board of Directors of the American Society of Clinical Psychopharmacology, and she is a Director on the Board of Directors of the Canadian Institute for Obsessive Compulsive Disorders. From 2002-2006 she chaired the National Institute of Mental Health's Interventions Research Review Committee (Scientific Review Group).
Dr. Phillips graduated Summa Cum Laude from Dartmouth College. She received her medical degree from Dartmouth Medical School and was elected to the Alpha Omega Alpha Honor Medical Society. She completed her psychiatry residency at McLean Hospital/Harvard Medical School. Dr. Phillips was a member of the full-time Brown medical school faculty for more than two decades; she was Professor of Psychiatry and Human Behavior from 2003-2018. For many years she was Senior Research Scientist, Director of the Body Dysmorphic Disorder Program, and Director of Research for Adult Psychiatry at Rhode Island Hospital in Providence, RI. She was also Director of Research Training for Brown University's General Psychiatry Residency Training Program.
Dr. Phillips has done hundreds of media interviews on her research on BDD. She has been interviewed by the New York Times, the London Times, the Los Angeles Times, the Wall Street Journal, the Washington Post, the Boston Globe, US News and World Report, Time Magazine, Newsweek, CNN, the BBC, National Public Radio, and many other media outlets. She has appeared on the Oprah Winfrey Show, 20/20, Dateline NBC, the Today Show, and Good Morning America.
Dr. Phillips has repeatedly been included in Best Doctors in America, Castle Connolly's America's Top Doctors, Who's Who in America, and Who's Who in the World. She has also been included in Marquis Who's Who in Science and Engineering, Who's Who in Medicine and Healthcare, and Who's Who of American Women.
| Weingarden, Hilary, Shaw, Ashley M., Phillips, Katharine A., Wilhelm, Sabine Shame and Defectiveness Beliefs in Treatment Seeking Patients With Body Dysmorphic Disorder. The Journal of Nervous and Mental Disease/The Journal of Nervous and Mental Disease. 2018; 206 (6) : 417-422. |
| Weingarden H, Shaw AM, Phillips KA, Wilhelm S Shame and Defectiveness Beliefs in Treatment Seeking Patients With Body Dysmorphic Disorder.. The Journal of Nervous and Mental Disease. 2018; 206 (6) : 417-422. |
|
Phillips KA
Appendix: Measures and resources.
2017;
|
|
Phillips KA
Assessment of body dysmorphic disorder: screening, diagnosis, severity, and insight. .
2017;
|
|
Phillips KA
Body dysmorphic disorder in children and adolescents. .
2017;
|
|
Body Dysmorphic Disorder: Advances in Research and Clinical Practice.
2017;
|
|
Veale D, Phillips KA, Neziroglu
Challenges in assessing and treating patients with body dysmorphic disorder and recommended approaches. .
2017;
|
|
Phillips KA
Classification of body dysmorphic disorder and relevance for patient care. .
Body Dysmorphic Disorder: Advances in Research and Clinical Practice. 2017;
|
|
Simmons R, Phillips KA
Core clinical features of body dysmorphic disorder: appearance preoccupations, negative emotions, core beliefs, and repetitive and avoidance behaviors. .
2017;
|
|
Phillips KA
Differentiating body dysmorphic disorder from normal appearance concerns and other mental disorders. .
2017;
|
|
Phillips KA
Insight and delusional beliefs in body dysmorphic disorder. .
2017;
|
| Phillips, Katharine A. New Insights on the Treatment of Hypochondriasis. American Journal of Psychiatry/American Journal of Psychiatry. 2017; 174 (8) : 719-720. |
|
Phillips KA
Pharmacotherapy and other somatic treatments for body dysmorphic disorder. .
2017;
|
|
Phillips KA
Suicidality and aggressive behavior in body dysmorphic disorder. .
2017;
|
|
Phillips KA
The obsessive-compulsive and related disorders: A new category in DSM-5. .
2017;
|
|
Phillips KA, Simmons R, Donahue J
Three patients with body dysmorphic disorder: cases and commentary. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice.
2017;
|
|
Phillips KA, Simmons R.
Treating a patient with body dysmorphic disorder using medication and cognitive-behavioral therapy: an illustrative case example.
2017;
|
| Kelly, Megan M., Phillips, Katharine A. Update on body dysmorphic disorder: clinical features, epidemiology, pathogenesis, assessment, and treatment. . Psychiatric Annals/Psychiatric Annals. 2017; 47 (11) : 552-558. |
| Phillips KA, Keshaviah A, Dougherty DD, Stout RL, Menard W, Wilhelm S Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.. American Journal of Psychiatry. 2016; 173 (9) : 887-895. |
| Phillips, Katharine A., Zai, Gwyneth, King, Nicole A., Menard, William, Kennedy, James L., Richter, Margaret A. A preliminary candidate gene study in body dysmorphic disorder. Journal of Obsessive-Compulsive and Related Disorders. 2015; 6 : 72-76. |
|
Handbook on Obsessive-Compulsive and Related Disorders. .
2015;
|
| Fineberg, Naomi A., Reghunandanan, Samar, Simpson, Helen B., Phillips, Katharine A., Richter, Margaret A., Matthews, Keith, Stein, Dan J., Sareen, Jitender, Brown, Angus, Sookman, Debbie Obsessive–compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults. Psychiatry research. 2015; 227 (1) : 114-125. |
| Kelly, Megan M., Zhang, Jinxin, Phillips, Katharine A. The prevalence of body dysmorphic disorder and its clinical correlates in a VA primary care behavioral health clinic. Psychiatry research. 2015; 228 (1) : 162-165. |
| Stein DJ, Craske MA, Friedman MJ, Phillips KA Anxiety disorders, obsessive-compulsive and related disorders, trauma- and stressor-related disorders, and dissociative disorders in DSM-5.. American Journal of Psychiatry. 2014; 171 (6) : 611-3. |
| Phillips KA Body dysmorphic disorder: common, severe and in need of treatment research.. Psychotherapy and Psychosomatics. 2014; 83 (6) : 325-9. |
| Phillips KA, Hart AS, Simpson HB, Stein DJ Delusional versus nondelusional body dysmorphic disorder: recommendations for DSM-5.. CNS Spectrums. 2014; 19 (1) : 10-20. |
| Bjornsson AS, Phillips KA Do obsessions and compulsions play a role in social anxiety disorder?. Harvard review of psychiatry. 2014; 22 (1) : 55-8. |
| Wilhelm S, Phillips KA, Didie E, Buhlmann U, Greenberg JL, Fama JM, Keshaviah A, Steketee G Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial.. Behavior Therapy. 2014; 45 (3) : 314-27. |
| Kelly MM, Didie ER, Phillips KA Personal and appearance-based rejection sensitivity in body dysmorphic disorder.. Body image. 2014; 11 (3) : 260-5. |
| Crerand, Canice E., Phillips, Katharine A. Reply to: ‘Patients with mild to moderate body dysmorphic disorder may benefit from rhinoplasty’. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2014; 67 (12) : 1754-1755. |
| Phillips KA, Menard W, Quinn E, Didie ER, Stout RL A 4-year prospective observational follow-up study of course and predictors of course in body dysmorphic disorder.. Psychological Medicine. 2013; 43 (5) : 1109-17. |
| Kelly MM, Dalrymple K, Zimmerman M, Phillips KA A comparison study of body dysmorphic disorder versus social phobia.. Psychiatry research. 2013; 205 (1-2) : 109-16. |
| Bjornsson AS, Didie ER, Grant JE, Menard W, Stalker E, Phillips KA Age at onset and clinical correlates in body dysmorphic disorder.. Comprehensive Psychiatry. 2013; 54 (7) : 893-903. |
|
Wilhelm S, Phillips KA, Steketee G.
Cognitive-Behavioral Therapy for Body Dysmorphic Disorder: A Treatment Manual. .
2013;
|
| Phillips KA, Menard W, Bjornsson AS Cued panic attacks in body dysmorphic disorder.. Journal of Psychiatric Practice. 2013; 19 (3) : 194-203. |
| Bjornsson AS, Phillips KA Do Obsessions and Compulsions Play a Role in Social Anxiety Disorder?. Harvard review of psychiatry. 2013; |
| Stein DJ, Phillips KA Patient advocacy and DSM-5.. BMC Medicine. 2013; 11 : 133. |
| Phillips KA, Hart AS, Menard W, Eisen JL Psychometric evaluation of the Brown Assessment of Beliefs Scale in body dysmorphic disorder.. The Journal of Nervous and Mental Disease. 2013; 201 (7) : 640-3. |
| Hart AS, Phillips KA Symmetry Concerns as a Symptom of Body Dysmorphic Disorder.. Journal of Obsessive-Compulsive and Related Disorders. 2013; 2 (3) : 292-298. |
| Phillips KA, Pinto A, Hart AS, Coles ME, Eisen JL, Menard W, Rasmussen SA A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder.. Journal of Psychiatric Research. 2012; 46 (10) : 1293-9. |
| Didie ER, Loerke EH, Howes SE, Phillips KA Severity of interpersonal problems in individuals with body dysmorphic disorder.. Journal of personality disorders. 2012; 26 (3) : 345-56. |
| Witte TK, Didie ER, Menard W, Phillips KA The relationship between body dysmorphic disorder behaviors and the acquired capability for suicide.. Suicide and Life-Threatening Behavior. 2012; 42 (3) : 318-31. |
| Black DW, Pfohl B, Blum N, McCormick B, Allen J, North CS, Phillips KA, Robins C, Siever L, Silk KR, Williams JB, Zimmerman M Attitudes toward borderline personality disorder: a survey of 706 mental health clinicians.. CNS Spectrums. 2011; 16 (3) : 67-74. |
| Phillips KA, Rogers J Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.. Child and Adolescent Psychiatric Clinics of North America. 2011; 20 (2) : 287-304. |
| Weingarden H, Marques L, Fang A, LeBlanc N, Buhlmann U, Phillips KA, Wilhelm S Culturally Adapted Cognitive Behavioral Therapy for Body Dysmorphic Disorder: Case Examples.. International Journal of Cognitive Therapy. 2011; 4 (4) : 381-396. |
| Stein DJ, Craske MG, Friedman MJ, Phillips KA Meta-structure issues for the DSM-5: how do anxiety disorders, obsessive-compulsive and related disorders, post-traumatic disorders, and dissociative disorders fit together?. Current Psychiatry Reports. 2011; 13 (4) : 248-50. |
| Wilhelm S, Phillips KA, Fama JM, Greenberg JL, Steketee G Modular cognitive-behavioral therapy for body dysmorphic disorder.. Behavior Therapy. 2011; 42 (4) : 624-33. |
| Phillips KA, Menard W Olfactory reference syndrome: demographic and clinical features of imagined body odor.. General Hospital Psychiatry. 2011; 33 (4) : 398-406. |
| Bjornsson AS, Dyck I, Moitra E, Stout RL, Weisberg RB, Keller MB, Phillips KA The Clinical Course of Body Dysmorphic Disorder in the Harvard/Brown Anxiety Research Project (HARP). The Journal of Nervous and Mental Disease/The Journal of Nervous and Mental Disease. 2011; 199 (1) : 55-7. |
|
Shahrokh NC, Hales RE, Phillips KA, Yudofsky SC.
The Language of Mental Health: A Glossary of Psychiatric Terms.
2011;
|
| Bjornsson AS, Didie ER, Phillips KA Body dysmorphic disorder.. Dialogues in Clinical Neuroscience. 2010; 12 (2) : 221-32. |
| Phillips KA, Wilhelm S, Koran LM, Didie ER, Fallon BA, Feusner J, Stein DJ Body dysmorphic disorder: some key issues for DSM-V.. Depression and Anxiety. 2010; 27 (6) : 573-91. |
| Didie ER, Kuniega-Pietrzak T, Phillips KA Body image in patients with body dysmorphic disorder: evaluations of and investment in appearance, health/illness, and fitness.. Body image. 2010; 7 (1) : 66-9. |
| Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL, Goodman WK, Phillips KA, Stein DJ Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.. Depression and Anxiety. 2010; 27 (6) : 507-27. |
| Feusner JD, Phillips KA, Stein DJ Olfactory reference syndrome: issues for DSM-V.. Depression and Anxiety. 2010; 27 (6) : 592-9. |
| Phillips KA Pharmacotherapy for Body Dysmorphic Disorder.. Psychiatric Annals. 2010; 40 (7) : 325-332. |
| Christopher PP, Boland RJ, Recupero PR, Phillips KA Psychiatric residents' experience conducting disability evaluations.. Acad Psychiatry. 2010; 34 (3) : 211-5. |
| Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, Fineberg N, Mataix-Cols D, Ferrão YA, Saxena S, Wilhelm S, Kelly MM, Clark LA, Pinto A, Bienvenu OJ, Farrow J, Leckman J Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?. Depression and Anxiety. 2010; 27 (6) : 528-55. |
| Stein DJ, Fineberg NA, Bienvenu OJ, Denys D, Lochner C, Nestadt G, Leckman JF, Rauch SL, Phillips KA Should OCD be classified as an anxiety disorder in DSM-V?. Depression and Anxiety. 2010; 27 (6) : 495-506. |
| Kelly MM, Walters C, Phillips KA Social anxiety and its relationship to functional impairment in body dysmorphic disorder.. Behavior Therapy. 2010; 41 (2) : 143-53. |
| Phillips KA, Friedman MJ, Stein DJ, Craske M Special DSM-V issues on anxiety, obsessive-compulsive spectrum, posttraumatic, and dissociative disorders.. Depression and Anxiety. 2010; 27 (2) : 91-2. |
| Crerand CE, Menard W, Phillips KA Surgical and minimally invasive cosmetic procedures among persons with body dysmorphic disorder.. Annals of plastic surgery. 2010; 65 (1) : 11-6. |
| Stein DJ, Phillips KA, Bolton D, Fulford KW, Sadler JZ, Kendler KS What is a mental/psychiatric disorder? From DSM-IV to DSM-V.. Psychological Medicine. 2010; 40 (11) : 1759-65. |
| Phillips KA, Menard W A prospective pilot study of levetiracetam for body dysmorphic disorder.. CNS Spectrums. 2009; 14 (5) : 252-60. |
| Sherrill JT, Sommers DI, Nierenberg AA, Leon AC, Arndt S, Bandeen-Roche K, Greenhouse J, Guthrie D, Normand SL, Phillips KA, Shear MK, Woolson R Integrating statistical and clinical research elements in intervention-related grant applications: summary from an NIMH workshop.. Acad Psychiatry. 2009; 33 (3) : 221-8. |
| Hrabosky JI, Cash TF, Veale D, Neziroglu F, Soll EA, Garner DM, Strachan-Kinser M, Bakke B, Clauss LJ, Phillips KA Multidimensional body image comparisons among patients with eating disorders, body dysmorphic disorder, and clinical controls: a multisite study.. Body image. 2009; 6 (3) : 155-63. |
| Stein DJ, Denys D, Gloster AT, Hollander E, Leckman JF, Rauch SL, Phillips KA Obsessive-compulsive disorder: diagnostic and treatment issues.. Psychiatric Clinics of North America. 2009; 32 (3) : 665-85. |
| Field KM, Jenkins MA, Friedlander ML, McKinley JM, Price MA, Weideman P, Keogh LA, McLachlan SA, Lindeman GJ, kConFab Investigators., Hopper JL, Butow PN, Phillips KA Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer.. European journal of cancer (Oxford, England : 1990). 2009; 45 (4) : 551-60. |
| Phillips KA, Kelly MM Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder.. International Clinical Psychopharmacology. 2009; 24 (1) : 26-8. |
| Feusner JD, Hembacher E, Phillips KA The mouse who couldn't stop washing: pathologic grooming in animals and humans.. CNS Spectrums. 2009; 14 (9) : 503-13. |
|
Phillips KA
Understanding Body Dysmorphic Disorder: An Essential Guide.
2009;
|
| Phillips KA, Didie ER, Feusner J, Wilhelm S Body dysmorphic disorder: treating an underrecognized disorder.. American Journal of Psychiatry. 2008; 165 (9) : 1111-8. |
| Phillips KA, Quinn G, Stout RL Functional impairment in body dysmorphic disorder: a prospective, follow-up study.. Journal of Psychiatric Research. 2008; 42 (9) : 701-7. |
| Didie ER, Menard W, Stern AP, Phillips KA Occupational functioning and impairment in adults with body dysmorphic disorder.. Comprehensive Psychiatry. 2008; 49 (6) : 561-9. |
| Hales RE, McDuffie JJ, Gabbard GO, Phillips K, Oldham J, Stewart DE Practical strategies for becoming a successful medical book author.. Acad Psychiatry. 2008; 32 (3) : 183-7. |
| Conroy M, Menard W, Fleming-Ives K, Modha P, Cerullo H, Phillips KA Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting.. General Hospital Psychiatry. 2008; 30 (1) : 67-72. |
| Phillips KA, Hollander E Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.. Body image. 2008; 5 (1) : 13-27. |
| Phillips KA, Didie ER, Menard W Clinical features and correlates of major depressive disorder in individuals with body dysmorphic disorder.. Journal of affective disorders. 2007; 97 (1-3) : 129-35. |
| Pagano ME, Phillips KA, Stout RL, Menard W, Piliavin JA Impact of helping behaviors on the course of substance-use disorders in individuals with body dysmorphic disorder.. Journal of Studies on Alcohol and Drugs. 2007; 68 (2) : 291-5. |
| Phillips KA, Pinto A, Menard W, Eisen JL, Mancebo M, Rasmussen SA Obsessive-compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders.. Depression and Anxiety. 2007; 24 (6) : 399-409. |
| Didie ER, Phillips KA Re: "Mortality among Canadian women with cosmetic breast implants".. American Journal of Epidemiology. 2007; 165 (7) : 846; author reply 846-7. |
| Phillips KA Suicidality in Body Dysmorphic Disorder.. Primary psychiatry. 2007; 14 (12) : 58-66. |
| Hunter-Yates J, Dufresne RG Jr, Phillips KA Tanning in body dysmorphic disorder.. Journal of the American Academy of Dermatology. 2007; 56 (5 Suppl) : S107-9. |
| Phillips KA, Kaye WH The relationship of body dysmorphic disorder and eating disorders to obsessive-compulsive disorder.. CNS Spectrums. 2007; 12 (5) : 347-58. |
| Kittler JE, Menard W, Phillips KA Weight concerns in individuals with body dysmorphic disorder.. Eating behaviors. 2007; 8 (1) : 115-20. |
| Phillips KA, Pagano ME, Menard W, Stout RL A 12-month follow-up study of the course of body dysmorphic disorder.. American Journal of Psychiatry. 2006; 163 (5) : 907-12. |
| Phillips KA An open-label study of escitalopram in body dysmorphic disorder.. International Clinical Psychopharmacology. 2006; 21 (3) : 177-9. |
| Kaplan GB, Phillips KA, Vaccaro A, Eisen JL, Posternak MA, MacAskill HS Assessment of insight into delusional beliefs in schizophrenia using the Brown Assessment of Beliefs Scale.. Schizophrenia research. 2006; 82 (2-3) : 279-81. |
| Phillips KA, Stout RL Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia.. Journal of Psychiatric Research. 2006; 40 (4) : 360-9. |
| Dyl J, Kittler J, Phillips KA, Hunt JI Body dysmorphic disorder and other clinically significant body image concerns in adolescent psychiatric inpatients: prevalence and clinical characteristics.. Child Psychiatry Hum Dev. 2006; 36 (4) : 369-82. |
| Coles ME, Phillips KA, Menard W, Pagano ME, Fay C, Weisberg RB, Stout RL Body dysmorphic disorder and social phobia: cross-sectional and prospective data.. Depression and Anxiety. 2006; 23 (1) : 26-33. |
| Didie ER, Tortolani CC, Pope CG, Menard W, Fay C, Phillips KA Childhood abuse and neglect in body dysmorphic disorder.. Child Abuse & Neglect. 2006; 30 (10) : 1105-15. |
| Phillips KA, Didie ER, Menard W, Pagano ME, Fay C, Weisberg RB Clinical features of body dysmorphic disorder in adolescents and adults.. Psychiatry research. 2006; 141 (3) : 305-14. |
| Ruffolo JS, Phillips KA, Menard W, Fay C, Weisberg RB Comorbidity of body dysmorphic disorder and eating disorders: severity of psychopathology and body image disturbance.. The International journal of eating disorders. 2006; 39 (1) : 11-9. |
| Phillips KA, Menard W, Pagano ME, Fay C, Stout RL Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.. Journal of Psychiatric Research. 2006; 40 (2) : 95-104. |
| Phillips KA, Menard W, Fay C Gender similarities and differences in 200 individuals with body dysmorphic disorder.. Comprehensive Psychiatry. 2006; 47 (2) : 77-87. |
| Castle DJ, Phillips KA Obsessive-compulsive spectrum of disorders: a defensible construct?. The Australian and New Zealand journal of psychiatry. 2006; 40 (2) : 114-20. |
| Grant JE, Menard W, Phillips KA Pathological skin picking in individuals with body dysmorphic disorder.. General Hospital Psychiatry. 2006; 28 (6) : 487-93. |
| Phillips KA, Pagano ME, Menard W Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 2006; 18 (4) : 251-7. |
| Didie ER, Tortolani C, Walters M, Menard W, Fay C, Phillips KA Social functioning in body dysmorphic disorder: assessment considerations.. The Psychiatric quarterly. 2006; 77 (3) : 223-9. |
| Phillips KA, Menard W Suicidality in body dysmorphic disorder: a prospective study.. American Journal of Psychiatry. 2006; 163 (7) : 1280-2. |
| Phillips KA, Conroy M, Dufresne RG, Menard W, Didie ER, Hunter-Yates J, Fay C, Pagano M Tanning in body dysmorphic disorder.. The Psychiatric quarterly. 2006; 77 (2) : 129-38. |
| Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, Jones MC, Gillson C, Searle S, Zhou Y, Kokocinski F, McDonald L, Evans R, Phillips K, Atkinson A, Cooper R, Jones C, Hall RE, Andrews TD, Lloyd C, Ainscough R, Almeida JP, Ambrose KD, Anderson F, Andrew RW, Ashwell RI, Aubin K, Babbage AK, Bagguley CL, Bailey J, Beasley H, Bethel G, Bird CP, Bray-Allen S, Brown JY, Brown AJ, Buckley D, Burton J, Bye J, Carder C, Chapman JC, Clark SY, Clarke G, Clee C, Cobley V, Collier RE, Corby N, Coville GJ, Davies J, Deadman R, Dunn M, Earthrowl M, Ellington AG, Errington H, Frankish A, Frankland J, French L, Garner P, Garnett J, Gay L, Ghori MR, Gibson R, Gilby LM, Gillett W, Glithero RJ, Grafham DV, Griffiths C, Griffiths-Jones S, Grocock R, Hammond S, Harrison ES, Hart E, Haugen E, Heath PD, Holmes S, Holt K, Howden PJ, Hunt AR, Hunt SE, Hunter G, Isherwood J, James R, Johnson C, Johnson D, Joy A, Kay M, Kershaw JK, Kibukawa M, Kimberley AM, King A, Knights AJ, Lad H, Laird G, Lawlor S, Leongamornlert DA, Lloyd DM, Loveland J, Lovell J, Lush MJ, Lyne R, Martin S, Mashreghi-Mohammadi M, Matthews L, Matthews NS, McLaren S, Milne S, Mistry S, Moore MJ, Nickerson T, O'Dell CN, Oliver K, Palmeiri A, Palmer SA, Parker A, Patel D, Pearce AV, Peck AI, Pelan S, Phelps K, Phillimore BJ, Plumb R, Rajan J, Raymond C, Rouse G, Saenphimmachak C, Sehra HK, Sheridan E, Shownkeen R, Sims S, Skuce CD, Smith M, Steward C, Subramanian S, Sycamore N, Tracey A, Tromans A, Van Helmond Z, Wall M, Wallis JM, White S, Whitehead SL, Wilkinson JE, Willey DL, Williams H, Wilming L, Wray PW, Wu Z, Coulson A, Vaudin M, Sulston JE, Durbin R, Hubbard T, Wooster R, Dunham I, Carter NP, McVean G, Ross MT, Harrow J, Olson MV, Beck S, Rogers J, Bentley DR, Banerjee R, Bryant SP, Burford DC, Burrill WD, Clegg SM, Dhami P, Dovey O, Faulkner LM, Gribble SM, Langford CF, Pandian RD, Porter KM, Prigmore E The DNA sequence and biological annotation of human chromosome 1.. J. Geophys. Res.. 2006; 441 (7091) : 315-21. |
| Phillips KA The Presentation of Body Dysmorphic Disorder in Medical Settings.. Primary psychiatry. 2006; 13 (7) : 51-59. |
| Phillips KA What physicians need to know about body dysmorphic disorder.. Medicine and health, Rhode Island. 2006; 89 (5) : 175-7. |
| Phillips KA, Grant JE, Siniscalchi JM, Stout R, Price LH A retrospective follow-up study of body dysmorphic disorder.. Comprehensive Psychiatry. 2005; 46 (5) : 315-21. |
| Pope CG, Pope HG, Menard W, Fay C, Olivardia R, Phillips KA Clinical features of muscle dysmorphia among males with body dysmorphic disorder.. Body image. 2005; 2 (4) : 395-400. |
| Phillips KA, Menard W, Fay C, Weisberg R Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder.. Psychosomatics. 2005; 46 (4) : 317-25. |
| Crerand CE, Phillips KA, Menard W, Fay C Nonpsychiatric medical treatment of body dysmorphic disorder.. Psychosomatics. 2005; 46 (6) : 549-55. |
| Phillips KA Olanzapine augmentation of fluoxetine in body dysmorphic disorder.. American Journal of Psychiatry. 2005; 162 (5) : 1022-3. |
| Phillips KA Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.. American Journal of Psychiatry. 2005; 162 (2) : 377-9. |
| Phillips KA, Pagano ME, Menard W, Fay C, Stout RL Predictors of remission from body dysmorphic disorder: a prospective study.. The Journal of Nervous and Mental Disease. 2005; 193 (8) : 564-7. |
| Phillips KA, Menard W, Fay C, Pagano ME Psychosocial functioning and quality of life in body dysmorphic disorder.. Comprehensive Psychiatry. 2005; 46 (4) : 254-60. |
| Grant JE, Phillips KA Recognizing and treating body dysmorphic disorder.. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 2005; 17 (4) : 205-10. |
| Eide MJ, Weinstock MA, Dufresne RG Jr, Neelagaru S, Risica P, Burkholder GJ, Upegui D, Phillips KA, Armstrong BK, Robinson-Bostom L Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin).. Journal of Investigative Dermatology. 2005; 124 (2) : 308-14. |
| Pinto A, Phillips KA Social anxiety in body dysmorphic disorder.. Body image. 2005; 2 (4) : 401-5. |
| Grant JE, Menard W, Pagano ME, Fay C, Phillips KA Substance use disorders in individuals with body dysmorphic disorder.. J. Clin. Psychiatry. 2005; 66 (3) : 309-16; quiz 404-5. |
| Phillips KA, Coles ME, Menard W, Yen S, Fay C, Weisberg RB Suicidal ideation and suicide attempts in body dysmorphic disorder.. J. Clin. Psychiatry. 2005; 66 (6) : 717-25. |
|
Phillips KA
The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. Revised and Expanded Edition. .
2005;
|
| Honigman RJ, Phillips KA, Castle DJ A review of psychosocial outcomes for patients seeking cosmetic surgery.. Plastic and Reconstructive Surgery. 2004; 113 (4) : 1229-37. |
| Phillips KA, Menard W Body dysmorphic disorder and art background.. American Journal of Psychiatry. 2004; 161 (5) : 927-8. |
| Castle DJ, Phillips KA, Dufresne RG Jr Body dysmorphic disorder and cosmetic dermatology: more than skin deep.. Journal of cosmetic dermatology. 2004; 3 (2) : 99-103. |
| Phillips KA Body dysmorphic disorder: recognizing and treating imagined ugliness.. World Psychiatry. 2004; 3 (1) : 12-7. |
| Phillips KA, Rasmussen SA Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study.. Psychosomatics. 2004; 45 (5) : 438-44. |
| Castle DJ, Molton M, Hoffman K, Preston NJ, Phillips KA Correlates of dysmorphic concern in people seeking cosmetic enhancement.. The Australian and New Zealand journal of psychiatry. 2004; 38 (6) : 439-44. |
| Phillips KA, Siniscalchi JM, McElroy SL Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder.. The Psychiatric quarterly. 2004; 75 (4) : 309-20. |
| Eisen JL, Phillips KA, Coles ME, Rasmussen SA Insight in obsessive compulsive disorder and body dysmorphic disorder.. Comprehensive Psychiatry. 2004; 45 (1) : 10-5. |
| Grant JE, Phillips KA Is anorexia nervosa a subtype of body dysmorphic disorder? Probably not, but read on.... Harvard review of psychiatry. 2004; 12 (2) : 123-6. |
| Phillips KA Psychosis in body dysmorphic disorder.. Journal of Psychiatric Research. 2004; 38 (1) : 63-72. |
| Holt DJ, Phillips KA, Shapiro ER, Becker AE "My Face Is My Fate": biological and psychosocial approaches to the treatment of a woman with obsessions and delusions.. Harvard review of psychiatry. 2003; 11 (3) : 142-54. |
| Rauch SL, Phillips KA, Segal E, Makris N, Shin LM, Whalen PJ, Jenike MA, Caviness VS Jr, Kennedy DN A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder.. Psychiatry research. 2003; 122 (1) : 13-9. |
|
Advancing DSM: Dilemmas in Psychiatric Diagnosis.
2003;
|
| Phillips KA, Najjar F An open-label study of citalopram in body dysmorphic disorder.. J. Clin. Psychiatry. 2003; 64 (6) : 715-20. |
| Gunstad J, Phillips KA Axis I comorbidity in body dysmorphic disorder.. Comprehensive Psychiatry. 2003; 44 (4) : 270-6. |
| Phillips KA, Albertini RS, Rasmussen SA A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.. Arch Gen Psychiatry. 2002; 59 (4) : 381-8. |
| Horowitz K, Gorfinkle K, Lewis O, Phillips KA Body dysmorphic disorder in an adolescent girl.. Journal of the American Academy of Child & Adolescent Psychiatry. 2002; 41 (12) : 1503-9. |
| Nierenberg AA, Phillips KA, Petersen TJ, Kelly KE, Alpert JE, Worthington JJ, Tedlow JR, Rosenbaum JF, Fava M Body dysmorphic disorder in outpatients with major depression.. Journal of affective disorders. 2002; 69 (1-3) : 141-8. |
| Phillips KA, Dufresne RG Jr Body dysmorphic disorder: a guide for primary care physicians.. Primary Care: Clinics in Office Practice. 2002; 29 (1) : 99-111, vii. |
| Carroll DH, Scahill L, Phillips KA Current concepts in body dysmorphic disorder.. Archives of Psychiatric Nursing. 2002; 16 (2) : 72-9. |
|
Disorders of Body Image. .
2002;
|
| Castle DJ, Honigman RJ, Phillips KA Does cosmetic surgery improve psychosocial wellbeing?. The Medical journal of Australia. 2002; 176 (12) : 601-4. |
| Massion AO, Dyck IR, Shea MT, Phillips KA, Warshaw MG, Keller MB Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder.. Arch Gen Psychiatry. 2002; 59 (5) : 434-40. |
| Phillips KA Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach.. CNS Spectrums. 2002; 7 (6) : 453-60, 463. |
|
Pope HG Jr, Phillips KA, Olivardia R.
The Adonis Complex: The Secret Crisis of Male
Body Obsession. .
2002;
|
| Phillips KA The obsessive-compulsive spectrums.. Psychiatric Clinics of North America. 2002; 25 (4) : 791-809. |
| Dufresne RG, Phillips KA, Vittorio CC, Wilkel CS A screening questionnaire for body dysmorphic disorder in a cosmetic dermatologic surgery practice.. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2001; 27 (5) : 457-62. |
| Phillips KA, Castle DJ Body dysmorphic disorder in men.. BMJ. 2001; 323 (7320) : 1015-6. |
| Regan L, Dufresne RG Jr, Phillips K Body dysmorphic disorder: a clinician's introduction.. Medicine and health, Rhode Island. 2001; 84 (9) : 292-3. |
| Phillips KA, McElroy SL, Dwight MM, Eisen JL, Rasmussen SA Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.. J. Clin. Psychiatry. 2001; 62 (2) : 87-91. |
| Phillips KA, Albertini RS, Siniscalchi JM, Khan A, Robinson M Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.. J. Clin. Psychiatry. 2001; 62 (9) : 721-7. |
| Atiullah N, Phillips KA Fatal body dysmorphic disorder by proxy.. J. Clin. Psychiatry. 2001; 62 (3) : 204-5. |
| Eisen JL, Rasmussen SA, Phillips KA, Price LH, Davidson J, Lydiard RB, Ninan P, Piggott T Insight and treatment outcome in obsessive-compulsive disorder.. Comprehensive Psychiatry. 2001; 42 (6) : 494-7. |
| Dyck IR, Phillips KA, Warshaw MG, Dolan RT, Shea MT, Stout RL, Massion AO, Zlotnick C, Keller MB Patterns of personality pathology in patients with generalized anxiety disorder, panic disorder with and without agoraphobia, and social phobia.. Journal of personality disorders. 2001; 15 (1) : 60-71. |
|
Somatoform and Factitious Disorders .
2001;
|
| Phillips KA, Castle DJ Somatoform disorders: a topic for education.. The British Journal of Psychiatry. 2001; 179 : 465-6. |
| Phillips KA, Grant J, Siniscalchi J, Albertini RS Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder.. Psychosomatics. 2001; 42 (6) : 504-10. |
| Phillips KA, Shea MT, Warshaw M, Dyck I, Bruce S, Keller M The relationship between comorbid personality disorders and treatment received in patients with anxiety disorders.. Journal of personality disorders. 2001; 15 (2) : 157-67. |
| Phillips KA, Dufresne RG Body dysmorphic disorder. A guide for dermatologists and cosmetic surgeons.. American journal of clinical dermatology. 2000; 1 (4) : 235-43. |
| Phillips KA Body dysmorphic disorder: diagnostic controversies and treatment challenges.. Bulletin of the Menninger Clinic. 2000; 64 (1) : 18-35. |
| Deckersbach T, Savage CR, Phillips KA, Wilhelm S, Buhlmann U, Rauch SL, Baer L, Jenike MA Characteristics of memory dysfunction in body dysmorphic disorder.. Journal of the International Neuropsychological Society. 2000; 6 (6) : 673-81. |
| Phillips KA, McElroy SL Personality disorders and traits in patients with body dysmorphic disorder.. Comprehensive Psychiatry. 2000; 41 (4) : 229-36. |
| Shea MT, Zlotnick C, Dolan R, Warshaw MG, Phillips KA, Brown P, Keller MB Personality disorders, history of trauma, and posttraumatic stress disorder in subjects with anxiety disorders.. Comprehensive Psychiatry. 2000; 41 (5) : 315-25. |
| Phillips KA Quality of life for patients with body dysmorphic disorder.. The Journal of Nervous and Mental Disease. 2000; 188 (3) : 170-5. |
| Phillips KA, Dufresne RG Jr, Wilkel CS, Vittorio CC Rate of body dysmorphic disorder in dermatology patients.. Journal of the American Academy of Dermatology. 2000; 42 (3) : 436-41. |
| Phillips KA Body dysmorphic disorder and depression: theoretical considerations and treatment strategies.. The Psychiatric quarterly. 1999; 70 (4) : 313-31. |
| Phillips KA, Gunderson JG Depressive personality disorder: fact or fiction?. Journal of personality disorders. 1999; 13 (2) : 128-34. |
| O'Sullivan RL, Phillips KA, Keuthen NJ, Wilhelm S Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine.. Psychosomatics. 1999; 40 (1) : 79-81. |
| Kronig MH, Apter J, Asnis G, Bystritsky A, Curtis G, Ferguson J, Landbloom R, Munjack D, Riesenberg R, Robinson D, Roy-Byrne P, Phillips K, Du Pont IJ Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.. Journal of Clinical Psychopharmacology. 1999; 19 (2) : 172-6. |
| Rothschild AJ, Phillips KA Selective serotonin reuptake inhibitors and delusional depression.. American Journal of Psychiatry. 1999; 156 (6) : 977-8. |
| Albertini RS, Phillips KA Thirty-three cases of body dysmorphic disorder in children and adolescents.. Journal of the American Academy of Child & Adolescent Psychiatry. 1999; 38 (4) : 453-9. |
| Phillips KA, Rasmussen SA, Price LH Treating imagined ugliness.. Arch Gen Psychiatry. 1999; 56 (11) : 1041-2. |
| Phillips KA, Gunderson CG, Mallya G, McElroy SL, Carter W A comparison study of body dysmorphic disorder and obsessive-compulsive disorder.. J. Clin. Psychiatry. 1998; 59 (11) : 568-75. |
| Phillips KA Body dysmorphic disorder: clinical aspects and treatment strategies.. Bulletin of the Menninger Clinic. 1998; 62 (4 Suppl A) : A33-48. |
| Phillips KA, Dwight MM, McElroy SL Efficacy and safety of fluvoxamine in body dysmorphic disorder.. J. Clin. Psychiatry. 1998; 59 (4) : 165-71. |
| Kaslow NJ, Thompson MP, Meadows LA, Jacobs D, Chance S, Gibb B, Bornstein H, Hollins L, Rashid A, Phillips K Factors that mediate and moderate the link between partner abuse and suicidal behavior in African American women.. Journal of Consulting and Clinical Psychology. 1998; 66 (3) : 533-40. |
| DeMarco LM, Li LC, Phillips KA, McElroy SL Perceived stress in body dysmorphic disorder.. The Journal of Nervous and Mental Disease. 1998; 186 (11) : 724-6. |
| Lyoo K, Gunderson JG, Phillips KA Personality dimensions associated with depressive personality disorder.. Journal of personality disorders. 1998; 12 (1) : 46-55. |
| Phillips KA, Gunderson JG, Triebwasser J, Kimble CR, Faedda G, Lyoo IK, Renn J Reliability and validity of depressive personality disorder.. American Journal of Psychiatry. 1998; 155 (8) : 1044-8. |
| Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA The Brown Assessment of Beliefs Scale: reliability and validity.. American Journal of Psychiatry. 1998; 155 (1) : 102-8. |
| Coffey BJ, Miguel EC, Biederman J, Baer L, Rauch SL, O'Sullivan RL, Savage CR, Phillips K, Borgman A, Green-Leibovitz MI, Moore E, Park KS, Jenike MA Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different?. The Journal of Nervous and Mental Disease. 1998; 186 (4) : 201-6. |
| Webster FB, Lean IJ, Kennedy D, Phillips K A case-control study to identify farm factors affecting fertility of dairy herds: univariate description of factors.. Australian veterinary journal. 1997; 75 (4) : 266-73. |
| Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale.. Psychopharmacology bulletin. 1997; 33 (1) : 17-22. |
| Phillips KA, Diaz SF Gender differences in body dysmorphic disorder.. The Journal of Nervous and Mental Disease. 1997; 185 (9) : 570-7. |
| Phillips KA, O'Sullivan RL, Pope HG Jr Muscle dysmorphia.. J. Clin. Psychiatry. 1997; 58 (8) : 361. |
| Pope HG Jr, Gruber AJ, Choi P, Olivardia R, Phillips KA Muscle dysmorphia. An underrecognized form of body dysmorphic disorder.. Psychosomatics. 1997; 38 (6) : 548-57. |
| Miguel EC, Baer L, Coffey BJ, Rauch SL, Savage CR, O'Sullivan RL, Phillips K, Moretti C, Leckman JF, Jenike MA Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome.. The British Journal of Psychiatry. 1997; 170 : 140-5. |
| Vittorio CC, Phillips KA Treatment of habit-tic deformity with fluoxetine.. Arch Dermatol. 1997; 133 (10) : 1203-4. |
| Phillips KA An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder.. Psychopharmacology bulletin. 1996; 32 (1) : 175-80. |
| McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI, Phillips KA, Strakowski SM Are impulse-control disorders related to bipolar disorder?. Comprehensive Psychiatry. 1996; 37 (4) : 229-40. |
| Albertini RS, Phillips KA, Guevremont D Body dysmorphic disorder.. Journal of the American Academy of Child & Adolescent Psychiatry. 1996; 35 (11) : 1425-6. |
| Phillips KA Body dysmorphic disorder: diagnosis and treatment of imagined ugliness.. J. Clin. Psychiatry. 1996; 57 Suppl 8 : 61-4; discussion 65. |
| Phillips KA Pharmacologic treatment of body dysmorphic disorder.. Psychopharmacology bulletin. 1996; 32 (4) : 597-605. |
| Phillips KA, Nierenberg AA, Brendel G, Fava M Prevalence and clinical features of body dysmorphic disorder in atypical major depression.. The Journal of Nervous and Mental Disease. 1996; 184 (2) : 125-9. |
|
Phillips KA
The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder.
1996;
|
| Soriano JL, O'Sullivan RL, Baer L, Phillips KA, McNally RJ, Jenike MA Trichotillomania and self-esteem: a survey of 62 female hair pullers.. J. Clin. Psychiatry. 1996; 57 (2) : 77-82. |
| Brawman-Mintzer O, Lydiard RB, Phillips KA, Morton A, Czepowicz V, Emmanuel N, Villareal G, Johnson M, Ballenger JC Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study.. American Journal of Psychiatry. 1995; 152 (11) : 1665-7. |
| Phillips KA, McElroy SL, Hudson JI, Pope HG Jr Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both?. J. Clin. Psychiatry. 1995; 56 Suppl 4 : 41-51; discussion 52. |
| Phillips KA, Kim JM, Hudson JI Body image disturbance in body dysmorphic disorder and eating disorders. Obsessions or delusions?. Psychiatric Clinics of North America. 1995; 18 (2) : 317-34. |
| Phillips KA, Atala KD, Albertini RS Case study: body dysmorphic disorder in adolescents.. Journal of the American Academy of Child & Adolescent Psychiatry. 1995; 34 (9) : 1216-20. |
| McElroy SL, Keck PE Jr, Phillips KA Kleptomania, compulsive buying, and binge-eating disorder.. J. Clin. Psychiatry. 1995; 56 Suppl 4 : 14-26; discussion 27. |
| Phillips KA, Taub SL Skin picking as a symptom of body dysmorphic disorder.. Psychopharmacology bulletin. 1995; 31 (2) : 279-88. |
| Phillips KA, McElroy SL, Keck PE Jr, Hudson JI, Pope HG Jr A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases.. Psychopharmacology bulletin. 1994; 30 (2) : 179-86. |
| Suppes T, Phillips KA, Judd CR Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases.. Biological Psychiatry. 1994; 36 (5) : 338-40. |
| McElroy SL, Phillips KA, Keck PE Jr Obsessive compulsive spectrum disorder.. J. Clin. Psychiatry. 1994; 55 Suppl : 33-51; discussion 52-3. |
| Kramlinger KG, Phillips KA, Post RM Rash complicating carbamazepine treatment.. Journal of Clinical Psychopharmacology. 1994; 14 (6) : 408-13. |
| Phillips KA, Nierenberg AA The assessment and treatment of refractory depression.. J. Clin. Psychiatry. 1994; 55 Suppl : 20-6. |
| Gunderson JG, Phillips KA, Triebwasser J, Hirschfeld RM The Diagnostic Interview for Depressive Personality.. American Journal of Psychiatry. 1994; 151 (9) : 1300-4. |
| Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI Body dysmorphic disorder: 30 cases of imagined ugliness.. American Journal of Psychiatry. 1993; 150 (2) : 302-8. |
| McElroy SL, Phillips KA, Keck PE Jr, Hudson JI, Pope HG Jr Body dysmorphic disorder: does it have a psychotic subtype?. J. Clin. Psychiatry. 1993; 54 (10) : 389-95. |
| Phillips KA, McElroy SL Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: theoretical and treatment implications.. The Journal of Nervous and Mental Disease. 1993; 181 (11) : 699-702. |
| Phillips KA, McElroy SL, Lion JR Plastic surgery and psychotherapy in the treatment of psychologically disturbed patients.. Plastic and Reconstructive Surgery. 1992; 90 (2) : 333-5. |
| Gunderson JG, Phillips KA A current view of the interface between borderline personality disorder and depression.. American Journal of Psychiatry. 1991; 148 (8) : 967-75. |
| Phillips KA Body dysmorphic disorder: the distress of imagined ugliness.. American Journal of Psychiatry. 1991; 148 (9) : 1138-49. |
| Phillips KA Pimozide in clinical psychiatry.. J. Clin. Psychiatry. 1991; 52 (12) : 514-5. |
| Phillips KA, Gunderson JG, Hirschfeld RM, Smith LE A review of the depressive personality.. American Journal of Psychiatry. 1990; 147 (7) : 830-7. |
| Phillips KA, Vaillant GE, Schnurr P Some physiologic antecedents of adult mental health.. American Journal of Psychiatry. 1987; 144 (8) : 1009-13. |
Dr. Phillips has done pioneering scientific research on body dysmorphic disorder (BDD), a common and severe disorder. Dr. Phillips has published more than 320 scientific articles, review articles, letters, and book chapters. To disseminate her research findings on BDD, she has also written books and lectures extensively in the US and abroad.
She has also conducted scientific research on obsessive-compulsive disorder, olfactory reference syndrome, and other disorders.
For more than 25 years, my scientific research has focused primarily on body dysmorphic disorder (BDD), a common and severe disorder that causes marked impairment in social and occupational/academic functioning and is associated with high rates of suicidality. I have also conducted studies focusing on obsessive-compulsive disorder, olfactory reference syndrome, and other psychiatric disorders.
When I started my research on BDD, virtually no systematic scientific research had been done on this underrecognized disorder, and thus very little was known about it. Because BDD causes so much suffering, my career has focused on discovering and advancing knowledge about this condition. The first major focus of my scientific research was to elucidate BDD's clinical features, such as BDD symptoms, suicidality, insight, co-occurring disorders, and impairment in psychosocial functioning, which created the foundation for future scientific inquiry. Because BDD-focused measures were not available, I developed and validated widely used BDD screening, diagnostic, severity, and insight measures for use by both researchers and clinicians. Effective treatments for BDD had not been identified, and thus a major focus of my work has been the identification, development, and testing of effective treatments for BDD, both psychotherapeutic and pharmacologic. I have also studied BDD's relationship to other disorders (such as obsessive-compulsive disorder and social anxiety disorder), its prevalence, and the course of BDD over time. I have additionally collaborated on neuroimaging, molecular genetics, and neuropsychological studies of BDD. A majority of my scientific publications focus primarily on BDD.
The overall goal of my past and ongoing work has been to better understand BDD and to develop effective treatments for BDD, an underrecognized and often debilitating disorder. I hope that this work, in turn, will alleviate the profound suffering and impairment that this condition so often causes.
Livingston Research Fellowship
Harvard Medical School
Principal Investigator, 1991-1992
Development of Diagnostic Instruments and Prevalence of Body
Dysmorphic Disorder in Psychiatric, Medical, and Surgical Populations
Young Investigator Award, National Alliance for Research on Schizophrenia and Depression (NARSAD)
Principal Investigator, 1992-1996
An Open-Label Flexible Dose Study of Fluvoxamine in Body Dysmorphic Disorder
Upjohn/Solvay Pharmaceuticals (Investigator Initiated)
Co-Principal Investigator, 1994-1995
A Prospective, Multicenter, Open-Label Study of Serzone (Nefazodone) in the Management of Patients with Symptoms of Depression in General Psychiatric Practices
Bristol-Myers Squibb Company
Co-Investigator, 1995
The Pharmacotherapy of Body Dysmorphic Disorder
National Institute of Mental Health (R29-MH54841 [FIRST Award])
Principal Investigator, 1995-2000
Pimozide Augmentation of Fluoxetine in Body Dysmorphic Disorder
Young Investigator Award, National Alliance for Research on Schizophrenia and Depression (NARSAD)
Principal Investigator, 1995-2002
Retrospective Follow-up Study of Body Dysmorphic Disorder
Department of Psychiatry, Brown Medical School
Principal Investigator, 1996-1998
Fluoxetine in the Continuation Treatment of Major Depressive Disorder
Eli Lilly and Company
Co-Investigator, 1997-1998
Phenomenology of Body Dysmorphic Disorder in Children and Adolescents
Solvay Pharmaceuticals (Investigator Initiated)
Co-Principal Investigator, 1997-2000
Harvard/Brown Anxiety Research Program
National Institute of Mental Health (5 R01 MH51415)
Co-Investigator, 1998-2008
Citalopram Treatment of Body Dysmorphic Disorder
Forest Laboratories (Investigator Initiated)
Principal Investigator, 1999-2001
Pharmacotherapy of Adolescent Body Dysmorphic Disorder
National Institute of Mental Health (1 R01 MH58750)
Principal Investigator, 1999-2003
Pilot Study of the Genetics of Body Dysmorphic Disorder
Department of Psychiatry, Brown Medical School
Principal Investigator, 1999-2003
Olanzapine Augmentation of Fluoxetine in Body Dysmorphic Disorder
Eli Lilly and Company (Investigator Initiated)
Principal Investigator, 1999-2003
Visual Processing in Body Dysmorphic Disorder
Department of Psychiatry, Brown Medical School
Principal Investigator, 2000-2001
Prospective Study of Body Dysmorphic Disorder
National Institute of Mental Health (R01 MH60241)
Principal Investigator, 2000-2006
Treatment and Psychopathology of Body Dysmorphic Disorder
National Institute of Mental Health: Mid-Career Investigator Award in Patient-Oriented Research (5K24 MH063975)
Principal Investigator, 2001-2013
Escitalopram Treatment of Body Dysmorphic Disorder
Forest Laboratories (Investigator Initiated)
Principal Investigator, 2003-2005
CBT Treatment Development in Body Dysmorphic Disorder
National Institute of Mental Health (R34 MH070490)
Co-Principal Investigator, 2004-2009
Open-Label Study of Levetiracetam in Body Dysmorphic Disorder
UCB Pharma (Investigator Initiated)
Principal Investigator, 2004-2008
Fluoxetine in Pediatric Body Dysmorphic Disorder
Food and Drug Administration (FD-R-002613)
Co-Principal Investigator, 2005-2012
Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder
National Institute of Mental Health (R01 MH072917)
Principal Investigator, 2005-2011
A Prospective Study of Suicidal Ideation, Suicide Attempts, and Completed Suicide in Body Dysmorphic Disorder
American Foundation for Suicide Prevention
Principal Investigator, 2007-2010
Safety of Low-Dose Ondansetron for Adjunctive Therapy in Adult Patients with Obsessive Compulsive Disorder Who Have Not Adequately Responded to Treatment with a Selective Serotonin Reuptake Inhibitor
Transcept Pharmaceuticals
Co-Investigator, 2011-2012
Cognitive-Behavioral Therapy Versus Supportive Psychotherapy for Body Dysmorphic Disorder
National Institute of Mental Health (R01 MH091023)
Principal Investigator, 2011-2017
Visual Processing in Body Dysmorphic Disorder
Brown Institute for Brain Science and Norman Prince Neurosciences Institute
Principal Investigator (with David Sheinberg, Ph.D.), 2013-2015
Promoting Research Training During Psychiatry Residency
National Institute of Mental Health (1R25 MH101076)
Principal Investigator, 2013-2018
Modification of Perception in Body Dysmorphic Disorder and Its Neural Correlates
Dean’s Emerging Areas of New Science (DEANS) Award, Brown University Division of Biology and Medicine
Principal Investigator, 2014-2016
Pathological Grooming in the Gabrg2 KO Mouse Model of Body Dysmorphic Disorder
National Institute of General Medical Sciences
Collaborative Mentor, 2014-2017
Partial publication listing:
Wilhelm S, Phillips KA, Greenberg JL, O’Keefe SM, Hoeppner SS, Keshaviah A, Sarvode-Mothi S, Schoenfeld DA. Efficacy and posttreatment effects of therapistdelivered cognitive behavioral therapy vs supportive psychotherapy for adults with body dysmorphic disorder: A randomized clinical trial. JAMA Psychiatry 2019;76:363-373
Greenberg JL, Phillips KA, Steketee G, Hoeppner SS, Wilhelm S. Predictors of response to cognitive-behavioral therapy for body dysmorphic disorder. Behavior Therapy 2019;50:839-849
Phillips KA (editor). Body Dysmorphic Disorder: Advances in Research and Clinical Practice. New York, NY: Oxford University Press, 2017
Phillips KA, Keshaviah A, Dougherty DD, Stout RL, Menard W, Wilhelm S. Pharmacotherapy relapse prevention in body dysmorphic disorder: A double-blind placebo-controlled trial. American Journal of Psychiatry 2016;173:887-895
Phillips KA, Stein DJ (editors). Handbook on Obsessive-Compulsive and Related Disorders. Arlington, VA: American Psychiatric Publishing, 2015
Wilhelm S, Phillips KA, Didie E, Buhlmann U, Greenberg JL, Fama JM, Keshaviah A, Steketee G. Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial. Behavior Therapy 2014:45:314-327
Phillips KA, Menard W, Quinn E, Didie ER, Stout RL. A four-year prospective observational follow-up study of course and predictors of course in body dysmorphic disorder. Psychological Medicine 2013;43:1109-1117
Wilhelm S, Phillips KA, Steketee G. Cognitive-Behavioral Therapy for Body Dysmorphic Disorder: A Treatment Manual. New York: Guilford Press, 2013
Phillips KA, Pinto A, Hart AS, Coles ME, Eisen JL, Menard W, Rasmussen SA. A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder. Journal of Psychiatric Research 2012;46:1293-1299
Phillips KA, Menard W. Olfactory reference syndrome: demographic and clinical features of imagined body odor. General Hospital Psychiatry 2011;33:398-406
Phillips KA, Wilhelm S, Koran LM, Didie ER, Fallon BA, Feusner J, Stein DJ. Body dysmorphic disorder: Some key issues for DSM-V. Depression and Anxiety 2010;27:573-591
Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, Fineberg N, Mataix-Cols D, Ferrão YA, Saxena S, Wilhelm S, Kelly MM, Clark LA, Pinto A, Bienvenu OJ, Farrow J, Leckman J. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depression and Anxiety 2010;27:528-555
Phillips KA. Body dysmorphic disorder. In: New Oxford Textbook of Psychiatry, Second Edition. Gelder M, Andreasen N, Lopez-Ibor J, Geddes J, eds. Oxford, England: Oxford University Press, 2009
Phillips KA, Kelly MM. Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder. International Clinical Psychopharmacology 2009;24:26-28
Phillips KA. Understanding Body Dysmorphic Disorder: An Essential Guide. New York: Oxford University Press, 2009
Phillips KA, Didie ER, Feusner J, Wilhelm S. Body dysmorphic disorder: treating an underrecognized disorder. American Journal of Psychiatry 2008;165:1111-1118
Phillips KA, Quinn G, Stout RL. Functional impairment in body dysmorphic disorder: a prospective, follow-up study. Journal of Psychiatric Research 2008;42:701-707
Phillips KA, Pinto A, Menard W, Eisen JL, Mancebo M, Rasmussen SA. Obsessive-
compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders. Depression and Anxiety 2007;24:399-409
Phillips KA, Pagano ME, Menard W, Stout RL. A 12-month follow-up study of the course of body dysmorphic disorder. American Journal of Psychiatry 2006;163:907-912
Phillips KA, Menard W, Fay C. Gender similarities and differences in 200 individuals with body dysmorphic disorder. Comprehensive Psychiatry 2006;47:77-87
Phillips KA, Menard W. Suicidality in body dysmorphic disorder: a prospective study. American Journal of Psychiatry 2006;163:1280-1282
Phillips KA. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. Revised and Expanded Edition. New York: Oxford University Press, 2005
Phillips KA, Coles M, Menard W, Yen S, Fay C, Weisberg RB. Suicidal ideation and suicide attempts in body dysmorphic disorder. Journal of Clinical Psychiatry 2005;66:717-725
Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Archives of General Psychiatry 2002;59:381-388
Pope HG Jr, Phillips KA, Olivardia R. The Adonis Complex: The Secret Crisis of Male Body Obsession. New York: The Free Press, 2000 (Paperback edition: The Adonis Complex: How to Identify, Treat, and Prevent Body Obsession in Men and Boys. New York: The Free Press, 2002)
Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. Journal of Clinical Psychiatry 1998;59:165-171
Phillips KA. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. New York, NY: Oxford University Press, 1996
Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry 1993;150:302-308
| Year | Degree | Institution |
|---|---|---|
| 1987 | MD | Dartmouth College |
| 1977 | AB | Dartmouth College |
Summa Cum Laude, Phi Beta Kappa, and Rufus Choate Scholar; Dartmouth College
Alpha Omega Alpha, Rolf Syvertsen Fellow for outstanding academic performance, and the Dean's Medal; Dartmouth Medical School
Outstanding Resident Award, National Institute of Mental Health
American Psychiatric Association/Burroughs-Wellcome Fellow, American Psychiatric Association
Resident Research Award, American Psychiatric Association
Psychiatric Research Fellowship Honorable Mention, American Psychiatric Association
Paul Howard Award, McLean Hospital
Marquis Who’s Who Among Human Services Professionals
Young Investigator Award, National Alliance for Research on Schizophrenia and Depression
New Investigator Travel Award Recipient; New Clinical Drug Evaluation Unit; National Institute of Mental Health
Outstanding Psychiatrist Award for Clinical Psychiatry, Massachusetts Psychiatric Society
Travel Award, American College of Neuropsychopharmacology
Honorable Mention, Gerald Klerman Award; National Alliance for Research on Schizophrenia and Depression
Literary Award (for The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder), Rhode Island Medical Women's Association
Research Mentor Award, Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, 2001, 2007, and 2015
Master of Arts ad eundem (honorary degree), Brown University
Department of Psychiatry and Human Behavior Research Mentor Award, The Warren Alpert Medical School of Brown University, 2001, 2007, and 2015
Best Doctors in America (National Edition), 2001-2003, 2005-2006, 2007-2008, 2009-2010, 2011-2014, 2015-2016, 2017-2019
2002 Dorfman Journal Paper Award, Academy of Psychosomatic Medicine
Distinguished Life Fellow, American Psychiatric Association
Special Presidential Commendation (for research on body dysmorphic disorder), American Psychiatric Association
Castle Connolly America's Top Doctors (national edition), 2007-19
American Men and Women of Science, 26th Edition, 2009
Marquis Who’s Who of American Women, 2010-2011
Marquis Who’s Who in America, 2010-2016
Fellow, American College of Neuropsychopharmacology, 2010-present
Marquis Who’s Who in Medicine and Healthcare, 2011-2012
US News and World Report Best Doctors, 2011-2013
Marquis Who’s Who in Science and Engineering, 2011-2012 and 2016-2017
Author Commendation (one of best authors in Psychiatry), UpToDate, 2017
Exceptional Women in Medicine (National Edition), Castle Connolly, 2017, 2018
Marquis Who’s Who Lifetime Achievement Award, 2017, 2018
Marquis Who's Who in the World, 2017, 2018, 2019, 2020
| Name | Title |
|---|---|
| Bath, Kevin | Joukowsky Family Assistant Professor of Cognitive, Linguistic and Psychological Sciences |
American Psychiatric Association (Distinguished Fellow)
International Society for the Study of Personality Disorders
International Obsessive-Compulsive Disorder Foundation (Member, Scientific and Clinical Advisory Board)
American College of Neuropsychopharmacology (Fellow)
American College of Psychiatrists
Anxiety and Depression Association of America (Member, Scientific Council)
Canadian Institute for Obsessive Compulsive Disorders (Director, Board of Directors)
American Society of Clinical Psychopharmacology (Board of Directors)
New York County Psychiatric Society
New York State Psychiatric Association
The New York Psychiatric Society (Elected Member)
| Licensed physician in New York | 2015-2017 |
| DeWitt Wallace Senior Scholar. 2018-Present |
| Adjunct Professor of Psychiatry and Human Behavior. 2018-2019 |
| Professor of Psychiatry . 2017- |
| Attending Psychiatrist. New York Presbyterian Hospital, 2017- |
From 2007-2017 Dr. Phillips was Director of Research Training for the General Psychiatry Residency Training Program at the Alpert Medical School of Brown University. She was also a Principal Investigator on an R-25 grant from the National Institute of Mental Health, which provides research training for general psychiatry residents at Brown University.
Dr. Phillips has provided research mentoring to beginning and early-career researchers (for example, junior faculty and residents). For more than a decade, she was Principal Investigator on a K24 grant from the National Institute of Mental Health, for which she provided research mentoring to many beginning researchers. Dr. Phillips additionally provides research teaching and mentoring at national scientific meetings, such as the annual meetings of the American Psychiatric Association and the American Society for Clinical Psychopharmacology.
Dr. Phillips is currently Residency Research Director for the Department of Psychiatry at Weill Cornell Medical College in New York City. She is also engaged in other teaching and mentoring activities for faculty, residents, and medical students at Weill Cornell Medicine.
